达尔巴万辛作为一种可行的替代方案,用于解决甲素耐药黄金葡萄球菌 (MRSA) 细菌病的治疗坚持:一个案例报告
Michael Sabina1, Jessica Cobian2, Imad Dibo3
1Internal Medicine, Lakeland Regional Health Medical Center, Lakeland, USA.
Cureus
|March 14, 2024
概括
门诊亲肠道抗生素治疗 (OPAT) 对无家可归患者来说可能是一个挑战. 每周一次的口服抗生素达尔巴万辛 (dalbavancin) 显示出有望改善这些困难病例的治疗效果和治疗效果.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 门诊亲肠道抗生素治疗 (OPAT) 旨在通过在医院之外治疗患者来降低医疗费用和感染风险.
- 患者坚持复杂的抗生素治疗方案是一个重大挑战,特别是在无家可归者等社会弱势群体.
- 频繁的剂量计划通常与较低的坚持率有关.
研究的目的:
- 评估每周服用一次口服抗生素达尔巴万辛的疗效,用于治疗患有耐美西林黄金葡萄球菌 (MRSA) 细菌病和骨髓炎的无家可归患者.
- 评估dalbavancin简化剂量的潜力,以改善面临社会经济挑战的患者的治疗坚持.
主要方法:
- 一个无家可归患者的案例研究,诊断出MRSA细菌病和骨髓炎.
- 用达尔巴万辛治疗,这是一种具有延长半衰期的口服抗生素,每周服用一次.
主要成果:
- 在病例患者中成功治疗MRSA细菌病和骨髓炎.
- 每周一次的达尔巴万辛治疗方案似乎有助于患者在挑战性的社会环境下坚持治疗.
结论:
- 达尔巴万辛的延长半衰期和简化剂量表可能是改善OPAT坚持和脆弱患者群体的结果的宝贵工具.
- 这一案例表明,达尔巴万辛可以成为在具有挑战性的门诊环境中治疗MRSA感染的有效选择.
更多相关视频
相关概念视频
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


